Understanding Menopause-Like Symptoms In Women In Their 30s
The perception that menopause-like symptoms occur only in older women is increasingly being challenged. A growing number of women in their 30s are experiencing symptoms traditionally associated with the menopausal transition. This phenomenon may indicate either perimenopause, the natural transitional period leading to menopause or, in rarer cases, premature menopause, defined as the cessation of ovarian function before the age of 40.
Both perimenopause and premature menopause share a common constellation of symptoms, including irregular periods, hot flashes, night sweats, vaginal dryness, sleep disturbances, mood changes, and urinary problems. While perimenopause typically begins in a woman's 40s, premature menopause affects a smaller proportion of women estimated at 1–3% representing a significantly earlier onset of these symptoms.
Dr. Preeti Rastogi, Director & HOD, Obstetrics & Gynaecology, Medanta, Gurugram, shares several key factors that may contribute to women in their 30s experiencing these symptoms:
Premature Ovarian Insufficiency (POI)
This condition involves the ovaries ceasing to function properly before age 40. The resulting decline in estrogen levels leads to menopause-like symptoms. Causes of POI can include genetic predispositions, autoimmune disorders, and, in some cases, idiopathic factors.
Certain medical treatments and procedures can impact ovarian function. Chemotherapy, radiation therapy, surgical removal of the ovaries (oophorectomy), or specific infections can damage the ovaries and trigger early menopausal symptoms.
Unhealthy lifestyle practices, such as smoking and excessive alcohol consumption, can increase the risk of early menopausal symptoms. Furthermore, autoimmune diseases or a family history of early menopause are recognized risk factors.
Hormonal Fluctuations
While natural hormone levels begin to decline subtly in the late 30s leading to mild symptoms for some women, this typically does not equate to full menopause. Symptoms at this age may also be confused with those arising from stress, lifestyle factors, or conditions such as Polycystic Ovary Syndrome (PCOS).
It is important to acknowledge that younger women can, indeed, experience these symptoms as early as their 30s, a phenomenon not commonly expected until their 40s. This represents a significant misconception that many women may be unaware of or may overlook.
Is This Normal?
No, the onset of menopause before the age of 40 is not considered normal. The majority of women experience menopause between the ages of 46 and 55. Premature symptoms often indicate a potential underlying medical condition and warrant a thorough medical evaluation.
What Should Women Do?
If you are in your 30s and experiencing significant menopause-like symptoms particularly skipped periods, hot flashes, or night sweats, it is imperative to consult a healthcare professional. Early diagnosis is crucial for effective symptom management and for addressing potential long-term health risks such as bone loss and cardiovascular disease.
Menopause-like symptoms in your 30s should not be ignored; they are uncommon and typically point to premature menopause or another underlying condition that requires medical attention.
view comments
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
11 hours ago
- Hindustan Times
Hormonal imbalance and mental health: Doctor shares 5 ways how hormones can affect your mood
Hormones, produced by endocrine glands, play a significant role in maintaining the bodily functions. Metabolism, sexual health, mental health and mood are determined by the hormonal balance of the body. In an interview with HT Lifestyle, Dr. Shwetal Gadhavi, senior consultant and HOD, preventive health services, HCG Hospitals. Ahmedabad explained how hormonal imbalances can affect mood and mental health, triggering anxiety, depression and mood swings. Also read | Common reasons of hormonal imbalance in women Hormonal imbalances can affect mood and mental health, triggering anxiety, depression and mood swings. (Freepik) 1. A chemical messenger: When the endocrine doesn't produce a sufficient number of hormones, an imbalance takes place. This imbalance of hormones can lead to problems with mental health, making issues like anxiety, mood swings, or depression worse. 2. Act of cortisol: A Drop in stress hormones, mostly cortisol, can impact mental health, as it affects blood sugar and insulin levels, which can further lower serotonin, a feel-good neurotransmitter. And estrogen can influence serotonin, which is present in the brain, making you feel calm and happy. 3. Thyroid and other health conditions: Similarly, our body's thyroid gland also produces energy hormones, and fluctuations in it can cause anxiety. Hormones can get disrupted due to various reasons like PCOS/PCOD, thyroid disorders, sedentary lifestyle, Cushing's syndrome, Addison's disease, menopause and chronic stress. It further tends to manifest anxiety, irritability, nervousness, mood swings, or even depression. Also read | Can you balance your hormones with diet, lifestyle changes? Doctor shares 9 things to do: 'Sleep for 7-8 hours' Anxiety, mood swings and depression is common in people with hormonal imbalances.(Shutterstock) 4. Imbalance in hormones and disruption in sleep: The hormone melatonin is responsible for sleep regulation but can get disrupted by cortisol and other hormonal imbalances. And lack of sleep can worsen anxiety, depression, and irritability, creating a vicious cycle. 5. Postpartum and hormonal imbalance: After childbirth, the hormones of women, that is, estrogen and progesterone levels, drop sharply, which is a major cause of postpartum depression or anxiety. When to see a doctor? If there are persistent mood changes, fatigue, or brain fog, it shouldn't be ignored, thinking it to be just stress. One should consult or go for a holistic evaluation when your body shows signs like tiredness, trouble sleeping, muscle pain, fatigue, trouble remembering things, frequent changes in the heart rate, digestive issues, greying or loss of hair, change in weight, etc. Also read | Do you have a hormonal imbalance? Signs to know and natural remedies for relief Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Time of India
21 hours ago
- Time of India
Can women get prostate cancer? Understanding the ‘female prostate', its function, and the rare risk of Skene's gland tumours
Female prostate cancer Most people learn in biology class that the prostate is unique to men. Yet human anatomy holds a small surprise: at the front wall of the vagina sits a pair of glands, the Skene's glands, that share many features with the male prostate. They contain the same enzymes (prostate-specific antigen and PSA phosphatase), may swell or become infected, and in exceptional cases can turn cancerous. According to Medical News Today, a 2017 literature review put the lifetime risk of true 'female prostate cancer' at a fraction of one percent of all genitourinary cancers in women. Still, because symptoms mimic more common problems such as cysts or recurrent urinary-tract infections, early tumours can be missed. Knowing what the female prostate does, how cancer might develop, and when to seek testing helps demystify a condition that—while rare—deserves a place on every clinician's diagnostic radar. What does the female prostate (Skene's glands) actually do Researchers using MRI and 3-D ultrasound have mapped these pea-sized glands around the urethra. The Skene's tissue produces a thin, alkaline fluid high in PSA—the same marker doctors track in men. Studies suggest this fluid may help protect the urinary tract from infection, contribute to arousal lubrication, and explain the G-spot's sensitivity. In people with polycystic ovary syndrome (PCOS) the glands are often enlarged, hinting that hormonal shifts influence their growth. How common is female prostate cancer According to Medical News Today, a 1994 database review found that Skene's gland tumours made up roughly 0.003 % of all documented cancers of the female urinary or genital tract—fewer than one case per 30 million women. Later reports confirm its rarity but caution that some urethral or vaginal cancers may originate in Skene's tissue and be mislabeled. Because awareness is low, pathologists now stain suspicious biopsies for PSA to avoid missed diagnoses. Female prostate cancer symptoms that overlap with more common conditions Palpable mass or firm lump near the vaginal opening Pain or burning during sex or urination Recurrent UTIs that resist standard antibiotics Unusual discharge sometimes streaked with blood These signs also occur with Skene's cysts, abscesses, or simple urethritis, which is why persistent symptoms after routine treatment should prompt imaging or referral to a uro-gynaecologist. Female prostate cancer diagnosis relies on PSA staining and imaging Pelvic MRI can reveal a solid lesion within the gland, but definitive diagnosis comes from a biopsy stained for PSA or PSAP. Elevated serum PSA has been reported in case studies, yet most clinicians use it only to monitor confirmed tumours, not to screen healthy women—the false-positive rate would be too high. Treatment mirrors protocols for other glandular cancers Because data are sparse, doctors adapt guidelines from urethral and prostate oncology: Surgical excision with clear margins is the primary approach for localised disease. Radiation or platinum-based chemotherapy may follow for aggressive histology or regional spread. Long-term outcomes are hard to predict, but individual case reports describe disease-free intervals of five years or more with early surgery. Female prostate cancer Related FAQs Do all women have a female prostate? Yes. The Skene's glands are part of typical female anatomy, though size varies from barely visible to several millimetres. Can a standard PSA blood test detect Skene's gland cancer early? Not reliably. PSA can rise from infection, cysts, or breast cancer; routine screening would create more confusion than benefit. It is mainly used to monitor known tumours. Are Skene's cysts precancerous? No. Cysts result from blocked ducts and carry no proven link to malignancy, but chronic inflammation may mask an underlying tumour, so persistent or recurrent cysts should be biopsied. Does PCOS increase the risk of female prostate cancer? Current studies show larger Skene's glands in PCOS, yet no direct rise in cancer incidence. Research is ongoing. What specialist treats Skene's gland disorders? Uro-gynaecologists and urologists with female pelvic-floor training typically manage diagnosis and surgery for Skene's conditions. Also read | Hair loss in females: 7 vitamin and mineral deficiencies every woman should check
&w=3840&q=100)
First Post
3 days ago
- First Post
Dr explains: How air pollution, stress and late pregnancies are fuelling India's fertility crisis
Infertility affects 10–15% of Indian couples. Firstpost brings out expert views on India's growing infertility crisis, examining how lifestyle, pollution, and delayed parenthood are affecting reproductive health, IVF success rates and access to fertility care in urban and tier-2 and tier-3 cities. read more Infertility is emerging as a pressing public health concern in India, affecting an estimated 10–15% of couples according to studies published in The Lancet and other medical journals. The issue has been further spotlighted by government data and clinical observations pointing to a surge in conditions like PCOS, endometriosis and declining sperm quality, particularly in urban centres. Environmental stressors such as air pollution and exposure to endocrine-disrupting chemicals, combined with sedentary lifestyles and delayed family planning, are compounding the crisis. The Indian Council of Medical Research and the Ministry of Health have taken regulatory steps with the Assisted Reproductive Technology (Regulation) Act to ensure standardised fertility care but challenges around accessibility, affordability and awareness persist—especially in tier-2 and tier-3 cities. STORY CONTINUES BELOW THIS AD Firstpost talked to Dr. Mannan Gupta, Chairman & HOD, Obstetrics & Gynaecology & IVF, Elantis Healthcare (New Delhi) to understand the underlying medical and environmental factors behind India's infertility burden, how air pollution and lifestyle are affecting IVF outcomes, and the current state of ART practices across the country. What are the main medical and environmental factors behind the rising burden of infertility in India? Dr Mannan: Infertility now affects nearly 10–15% of couples in India, and the trend is steadily increasing. Medically, rising cases of Polycystic Ovary Syndrome (PCOS), endometriosis, thyroid disorders, diabetes, and obesity in women are significant contributors. In men, conditions like varicocele, hormonal imbalances, and poor sperm parameters are commonly seen. Environmentally, increasing exposure to endocrine-disrupting chemicals (EDCs), air pollution, and unhealthy lifestyle habits—such as poor diet, lack of exercise, smoking, alcohol consumption, and chronic stress—are worsening reproductive health. Additionally, delayed marriages and late pregnancy planning have become major socio-cultural factors contributing to declining fertility. How are declining sperm quality and ovarian reserve due to air pollution and sedentary lifestyles impacting IVF outcomes, especially in urban India? Dr Mannan: In urban settings, declining sperm counts and ovarian reserves have become major challenges for successful conception—both naturally and via assisted reproduction. Studies show increasing DNA fragmentation in sperm and diminished anti-Müllerian hormone (AMH) levels in women exposed to high-pollution environments. These directly reduce embryo quality and negatively impact IVF success rates. Sedentary habits, obesity, and poor sleep hygiene further impair hormonal health. As a result, we often require multiple IVF cycles and personalised stimulation protocols to achieve a viable pregnancy, especially in metropolitan cities. How accessible and affordable is IVF treatment across India, particularly in tier-2 and tier-3 cities? Dr Mannan: While IVF is gaining popularity and acceptance, affordability and access remain significant hurdles outside metro cities. In tier-2 and tier-3 areas, there is limited availability of advanced infrastructure, skilled embryologists, and fertility specialists. Many couples are forced to travel to metro cities, which increases emotional and financial burdens. Moreover, infertility is still considered taboo in several regions, leading to delayed medical intervention. Although some states are considering subsidised treatment or insurance coverage for infertility, there is still a long way to go in terms of accessibility and affordability at the national level. STORY CONTINUES BELOW THIS AD What realistic expectations should couples, especially those over 35, have when starting IVF? Dr Mannan: IVF success rates typically range from 30% to 50%, depending on factors like the woman's age, the cause of infertility, and the clinic's expertise. For women above 35, success rates start to decline due to reduced ovarian reserve and egg quality. It is crucial for couples to understand that IVF is not a guarantee of pregnancy in the first cycle. It may require two or more attempts, and in some cases, advanced techniques like donor eggs or preimplantation genetic testing (PGT) may be recommended. Emotional and psychological support also plays a big role during this journey. Since the implementation of ICMR guidelines and ART legislation, how have clinical practices, patient safety, and ethical standards changed? Dr Mannan: The Assisted Reproductive Technology (Regulation) Act and ICMR guidelines have brought much-needed standardisation to IVF practices across India. Clinics now require mandatory registration, ensuring quality control and accountability. There are clear protocols for consent, gamete donation, surrogacy, and embryo storage. This has significantly improved patient safety, reduced unethical practices, and built greater transparency in treatment. While compliance can sometimes increase operational costs, it ultimately enhances trust between patients and healthcare providers. STORY CONTINUES BELOW THIS AD Are clinics in India adopting single embryo transfer more frequently to minimise complications from multiple pregnancies? Dr Mannan: Yes, there is a growing shift towards single embryo transfer (SET), especially in younger women with good-quality embryos. While earlier practices often involved transferring two or more embryos to boost chances, we now understand that multiple pregnancies increase maternal risks such as hypertension, preterm birth, and NICU admissions. With improved embryo culture systems, blastocyst transfers, and technologies like vitrification (rapid freezing), SET has become a safe and effective option. However, adoption still varies across clinics and regions based on patient preference, cost considerations, and expectations. What does current evidence suggest about egg freezing and fertility preservation in working women and cancer patients? Dr Mannan: Egg freezing has emerged as a valuable tool for fertility preservation. For working women who wish to delay childbearing, freezing eggs before the age of 35 offers the best chance of future success. In cancer patients, fertility preservation before undergoing chemotherapy or radiotherapy is becoming standard practice. Evidence shows that frozen eggs, when used within 5–10 years, can lead to pregnancy rates comparable to fresh eggs—provided they were retrieved at an optimal age and under proper protocols. The key is early counselling and timely decision-making. STORY CONTINUES BELOW THIS AD How widely are advanced technologies like AI and time-lapse imaging being adopted in Indian IVF clinics, and do they improve outcomes? Dr Mannan: Advanced technologies such as AI-based embryo selection and time-lapse imaging (like EmbryoScope) are being increasingly integrated into top-tier IVF centres in India. These tools offer real-time monitoring of embryo development and help identify embryos with the best implantation potential. AI algorithms analyse thousands of data points to assist embryologists in decision-making. While the evidence is promising—especially in reducing subjectivity and improving selection accuracy—more long-term data is needed to confirm significant improvements in live birth rates. Cost is another limiting factor, making these technologies less accessible in smaller cities.
